One year in review
Idiopathic inflammatory myopathies: one year in review 2022
E. Dourado1, F. Bottazzi2, C. Cardelli3, E. Conticini4, J. Schmidt5, L. Cavagna6, S. Barsotti7
- Rheumatology Department, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, and Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal.
- Department of Internal Medicine and Therapeutics, Università di Pavia, and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.
- Department of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Italy.
- Department of Neurology and Pain Treatment, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, and Department of Neurology, Neuromuscular Centre, University Medical Centre Göttingen, Germany.
- Department of Internal Medicine and Therapeutics, Università di Pavia, and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Internal Medicine, Livorno Hospital, Livorno, Italy. simone.barsotti.pisa@gmail.com
CER16499
2023 Vol.41, N°2
PI 0199, PF 0213
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 36826800 [PubMed]
Received: 04/01/2023
Accepted : 06/01/2023
In Press: 15/02/2023
Published: 01/03/2023
Abstract
Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of disorders in which chronic inflammation of the skeletal muscle, leading to muscle weakness, is a common feature. Different phenotypes have been identified within the IIM spectrum based on extra-muscular manifestations, immunology, muscle histology, responsiveness to therapy, and prognosis. The pathogenesis, classification, treatment, and prognosis of the different IIM subtypes are subject to active discussion and research. This review highlights the most relevant literature published on this topic over the last year.
